RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
AI-Driven Revolution | Explore RadNet's integration of AI in diagnostic imaging, positioning it as a frontrunner in healthcare technology and potentially reducing administrative costs by 25% |
Financial Projections | RadNet's EPS estimates for FY 2025 and 2026 are $0.35 and $0.58 respectively, with analysts maintaining an optimistic view despite recent AI revenue decline |
Market Dominance | As the largest U.S. radiology business, RadNet leverages its extensive network and early AI adoption to maintain a competitive edge in speed and integration capabilities |
Future Growth Catalysts | Delve into RadNet's AI-powered cancer screening tools, which show promise for increased adoption and favorable reimbursement policies, opening new revenue streams |
Metrics to compare | RDNT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRDNTPeersSector | |
---|---|---|---|---|
P/E Ratio | −1,040.3x | −0.8x | −0.6x | |
PEG Ratio | 5.49 | −0.01 | 0.00 | |
Price/Book | 5.1x | 0.8x | 2.6x | |
Price / LTM Sales | 2.6x | 0.6x | 3.1x | |
Upside (Analyst Target) | 35.4% | 56.1% | 55.2% | |
Fair Value Upside | Unlock | 30.1% | 9.8% | Unlock |